Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Livio Garattini

Showing results (31-40 of 161) with videos related to

Pageof 17
Sort By:
British Journal of Clinical Pharmacology|December 5, 2025
Community pharmacies in Italy: An inevitably growing role?Livio Garattini, Bruno Finazzi
Applied Health Economics and Health Policy|March 19, 2016
'Appropriateness' in Italy: A 'Magic Word' in Pharmaceuticals?Livio Garattini, Anna Padula
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 28, 2019
Defensive medicine in Europe: a 'full circle'?Livio Garattini, Anna Padula
Journal of the Royal Society of Medicine|November 16, 2019
Health technology assessment for pharmaceutical regulation in the European Union: do we need another body?Anna Padula, Livio Garattini
Journal of the Royal Society of Medicine|December 21, 2019
Pharmaceutical expenditure control in Europe: time to move from pricing to budgeting?Livio Garattini, Anna Padula
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|January 11, 2020
Defensive medicine in Europe: a 'full circle'?Livio Garattini, Anna Padula
Applied Health Economics and Health Policy|February 5, 2020
Comment on: 'Value-Based Pricing Alternatives for Personalised Drugs: Implications of Asymmetric Information and Competition'Livio Garattini, Nick Freemantle
Journal of the Royal Society of Medicine|December 4, 2018
Competition in health markets: is something rotten?Livio Garattini, Anna Padula
Applied Health Economics and Health Policy|November 29, 2021
Pharmaceutical Patents in Europe: Radical Reforms Rather Than Getting Rid?Livio Garattini, Bruno Finazzi
Croatian Medical Journal|June 13, 2019
Precision medicine and monoclonal antibodies: breach of promise?Livio Garattini, Anna Padula
Pageof 17

Showing results (31-40 of 161) with videos related to

Sort By:
Pageof 17
British Journal of Clinical Pharmacology|December 5, 2025
Community pharmacies in Italy: An inevitably growing role?Livio Garattini, Bruno Finazzi
Applied Health Economics and Health Policy|March 19, 2016
'Appropriateness' in Italy: A 'Magic Word' in Pharmaceuticals?Livio Garattini, Anna Padula
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 28, 2019
Defensive medicine in Europe: a 'full circle'?Livio Garattini, Anna Padula
Journal of the Royal Society of Medicine|November 16, 2019
Health technology assessment for pharmaceutical regulation in the European Union: do we need another body?Anna Padula, Livio Garattini
Journal of the Royal Society of Medicine|December 21, 2019
Pharmaceutical expenditure control in Europe: time to move from pricing to budgeting?Livio Garattini, Anna Padula
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|January 11, 2020
Defensive medicine in Europe: a 'full circle'?Livio Garattini, Anna Padula
Applied Health Economics and Health Policy|February 5, 2020
Comment on: 'Value-Based Pricing Alternatives for Personalised Drugs: Implications of Asymmetric Information and Competition'Livio Garattini, Nick Freemantle
Journal of the Royal Society of Medicine|December 4, 2018
Competition in health markets: is something rotten?Livio Garattini, Anna Padula
Applied Health Economics and Health Policy|November 29, 2021
Pharmaceutical Patents in Europe: Radical Reforms Rather Than Getting Rid?Livio Garattini, Bruno Finazzi
Croatian Medical Journal|June 13, 2019
Precision medicine and monoclonal antibodies: breach of promise?Livio Garattini, Anna Padula
Pageof 17